awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40654455-4AD49994-8F42-43BC-9A7F-6261E950405C
Q40654455-4AD49994-8F42-43BC-9A7F-6261E950405C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40654455-4AD49994-8F42-43BC-9A7F-6261E950405C
Novel biomarker and easy to perform ELISA for monitoring complement inhibition in patients with atypical hemolytic uremic syndrome treated with eculizumab.
P2860
Q40654455-4AD49994-8F42-43BC-9A7F-6261E950405C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40654455-4AD49994-8F42-43BC-9A7F-6261E950405C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
76c35ae24e0d855017a9b670f3385e26b919267b
P2860
Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies